Aberrant expression of CD19 as a marker of monocytic lineage in acute myelogenous leukemia

American Journal of Clinical Pathology

Volumn 107, Issue 3, 1997, Pages 283-291

  Brandt, John T ^a   Tisone, Joseph A ^a   Bohman, Jo Ellen ^a   Theil, Karl S ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Acute monocytic leukemia; Acute myelomonocytic leukemia; CD19, Classification of acute myeloid leukemia; Flow cytometry); Immunophenotyping

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD11B ANTIGEN; CD14 ANTIGEN; CD19 ANTIGEN; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031040109     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/107.3.283     Document Type: Article

References (47)

1. Bernard A, Boumsell L, Hill C. Joint report of the First International Workshop on Human Leukocyte Differentiation Antigens by the investigators of the participating laboratories. In: Bernard A, Boumsell L, Dausset J, Milstein C, Schlossan SF, eds. Leukocyte Typing: Human Leukocyte Differentiation Antigens Selected By Monoclonal Antibodies. New York, NY: Springer-Verlag; 1984:9-142.
2. Knapp W, Dorken B, Gilks WR, et al., eds. Leukocyte Typing IV: White Cell Differentiation Antigens. New York, NY: Oxford University Press; 1989.
3. Goasgen JE, Kitchingman GR, Mirro J, Stass S. Lineage heterogeneity in acute leukemia. In: Knowles DM, ed. Neoplastic Hematopathology. Baltimore, Md: Williams & Wilkins; 1992:1351-1365.
4. Stass S, Mirro J. Unexpected heterogeneity in acute leukemia: mixed lineages and lineage switch. Hum Pathol. 1985;16:864-866.
5. Stass SA, Mirro J. Lineage heterogeneity in acute leukaemia: acute mixed lineage switch. Clini Haematol. 1986;15:811-827.
6. Simpson EM, Mott MG. Hybrid leukaemia of T cell and myeloid lineages: cytogenetic distinction from second (induced) malignancy. Br J Haematol. 1987;165:401-403.
7. Eridani S, Chan LC, Halil O, et al. Acute biphenotypic leukaemia (myeloid and null-ALL type) supervening in a myelodysplastic syndrome. Br J Haematol. 1985;61:525-529.
8. Neame PB, Soamboonsrup P, Quigley JG, Pewarchuck W. The use of monoclonal antibodies and immune markers in the diagnosis, prognosis, and therapy of acute leukemia. Trans Med Rev. 1994;8:59-75.
9. Neame PB, Soamboonsrup P, Browman GP, et al. Classifying acute leukemia by immunophenotyping: a combined FAB-immunologic classification of AML. Blood. 1986;68:1355-1362.
10. Braun MP, Martin PJ, Ledbetter JA, et al. Granulocytes and cultured human fibroblasts express common acute lymphoblastic leukemia associated antigens. Blood. 1983;61:718-725.
11. LeMaistre A, Childs CC, Hirsch-Ginsberg C, et al. Heterogeneity in acute undifferentiated leukemia. Hematol Pathol. 1988;2:79-90.
12. Bradstock K, Matthews J, Benson E, et al. Prognostic value of immunophenotyping in acute myeloid leukemia. Blood. 1994;84:1220-1225.
13. Deegan MJ. Membrane antigen analysis in the diagnosis of lymphoid leukemias and lymphomas. Arch Pathol Lab Med. 1989;113:606-618.
14. Foon KA, Todd RF. Immunologic classification of leukemia and lymphoma. Blood. 1986;68:1-31.
15. Oster W, Konig K, Ludwig WD, et al. Incidence of lineage promiscuity in acute myeloblastic leukemia: diagnostic implications of immunoglobulin and T cell receptor gene rearrangement analysis and immunological phenotyping. Leuk Res. 1988;12:887-895.
16. Neame PB, Soamboonsrup, Browman G, et al. Simultaneous or sequential expression of the lymphoid and myeloid phenotypes in acute leukemia. Blood. 1985;65:142-148.
17. Mirro J, Zipf TF, Pui C-H, et al. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance. Blood. 1985;66:1115-1123.
18. Paietta E, Van Ness B, Bennett J, et al. Lymphoid lineage-associated features in acute myeloid leukemia: phenotypic and genotypic correlations. Br J Haematol. 1992;82:324-331.
19. Hanson CA, Abaza M, Sheldon S, Ross CW, Schnitzer B, Stoolman L. Acute biphenotypic leukemia: immunophenotypic and cytogenetic analysis. Br J Haematol. 1992;84:49-60.
20. Ball ED, Davis RB, Griffin JD, et al. Prognostic value of lymphocytic surface markers in acute myeloid leukemia. Blood. 1991;77:2242-2250.
21. Smith LJ, Curtis JE, Messner HA, et al. Lineage infidelity in acute leukemia. Blood. 1983;61:1138-1145.
22. Greaves MF, Chan LC, Furley AJW, Watt SM, Molgaard HV. Lineage promiscuity in hematopoietic differentiation and leukemia. Blood. 1986;67:1-11.
23. Larson RS, McCurley TL. CD4 predicts nonlymphocytic lineage in acute leukemia. Am J Clin Pathol. 1995;104:204-211.
24. Saikevych IA, Kerrigan DP, McConnell TS, et al. Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology. Leukemia. 1991;5:373-382.
25. Ball ED. Immunophenotyping of acute myeloid leukemia cells. Clin Lab Med. 1990;10:721-736.
26. Knapp W, Dorken B, Rieber P, et al. CD antigens 1989. Blood. 1989;74:1448-1450.
27. Stockinger H, Majdic O, Knapp W. 1995 directory for the human leukocyte clusters of differentiation. Transfusion. 1996;36:268-285.
28. Pontvert-Deueq S, Breton-Gorius J, Schmitt C, et al. Characterization and functional analysis of adult human bone marrow cell subsets in relation to B-lymphoid development. Blood. 1993;82:417-429.
29. Fearson DT. The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B-lymphocytes. Curr Opin Immunol. 1993;5:341-348.
30. Ling NR, MacLennan ICM, Mason D. B cell antigens: new and previously defined clusters. In: McMichael AJ, ed. Leukocyte Typing III: White Cell Differentiation Antigens. New York, NY: Oxford University Press;1986:302-335.
31. Nadler LM, Korsmeyer SJ, Anderson K, et al. B cell origin of non T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest. 1984;74:332-339.
32. Pezzutto A, Dorken B, Rabinovitch PS, et al. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. J Immunol. 1987;138:2793-2797.
33. Keren DF, Hanson CA, Hurtubise PE. Flow Cytometry and Clinical Diagnosis. Chicago, Ill: ASCP Press; 1993:676.
34. Hurwitz CA, Raimondi SC, Head D, et al. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood. 1992;80:3182-3188.
35. Porwit-MacDonald A, Janossy G, Ivory K, et al. Leukemia-associated changes identified by quantitative flow cytometry, IV: CD34 overexpression in acute myelogenous leukemia M2 with t(8;21). Blood. 1996;87:1162-1169.
36. Kita K, Nakase K, Miwa H, et al. Phenotypical characteristics of acute myelocytic leukemia associated with t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood. 1992;80:470-477.
37. Bennett JM, Catovsky D, Daniel M-T, et al. Proposals for the classification of acute leukemias French-American-British (FAB) co-operative group. Br J Haematol. 1976;3:451-158.
38. Bennett JM, Catovsky D, Daniel MT, et al. The morphological classification of acute lymphoblastic leukemia: Concordance among observers and clinical correlations. Br J Haematol. 1981;47:553-561.
39. Borowitz MJ, Guenther KL, Shults KE, Stelzer GT. Immunophenotyping of acute leukemia by flow cytometric analysis. Am J Clin Pathol. 1993;100:534-540.
40. Mitelman F, ed. ISCN (1995): an International System for Cytogenelic Nomenclature. Basel, Switzerland: S Karger; 1995.
41. Nadler LM, Anderson KC, Marti G, et al. B4, a human B-lymphocyte associated antigen expressed on normal, mitogen activated, and malignant B-lymphocytes. J Immunol. 1983;131:244-250.
42. Heim S, Mitelman F. Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells. 2nd ed. New York, NY: Wiley-Liss Inc; 1995:85-90.
43. Campos L, Guyotat D, Gentilhomme O, et al. Expression of a B-lymphoid differentiation antigen (CD19) on acute non-lymphoblastic leukaemia cells. Eur J Haematol. 1987;38:220-224.
44. Campos L, Guyotat D, Larese A, et al. Expression of CD19 antigen on acute monoblastic leukemia cells at diagnosis and after TPA-induced differentiation. Leuk Res. 1988;12:369-372.
45. Traweek ST. Immunophenotypic analysis of acute leukemia. Am J Clin Pathol 1993;99:504-512.
46. Griffin JD. The use of monoclonal antibodies in the characterization of myeloid leukemias. Hematol Pathol 1987;1:81-91.
47. Drexler HG. Classification of acute myeloid leukemias: a comparison of FAB and immunophenotyping. Leukemia. 1987;10:697-705.